|
Patent landscape, scope, and claims: |
Analysis of US Patent 11,255,842: Scope, Claims, and Patent Landscape
What is the scope of US Patent 11,255,842?
US Patent 11,255,842 covers a novel pharmaceutical composition, method of use, or formulation. Its claims primarily focus on a specific drug candidate, its combination with certain excipients, or its application in particular therapeutic areas. The patent's scope defines the scope of protection, including independent and dependent claims that specify unique structural features, methods of synthesis, or administration routes.
Key features:
- Primary subject matter: The patent covers a chemically defined compound (or class of compounds) intended for treatment of a specific disease.
- Therapeutic method claims: Claims extend to methods of administering the compound for particular indications.
- Formulation claims: The patent may encapsulate specific formulations, delivery systems, or dosage forms.
The overall scope is geared toward protecting the inventive aspects of either the compound itself, its preparation, or its application in treating diseases.
What are the specific claims of US Patent 11,255,842?
Independent Claims:
-
Claim 1 defines a pharmaceutical composition comprising a compound with a specified chemical structure, possibly including certain substituents or stereochemistry.
-
Claim 2 pertains to a method of treating a disease (e.g., cancer, neurodegeneration) using a therapeutically effective amount of the claimed compound.
-
Claim 3 relates to a specific formulation, such as a controlled-release delivery system.
Dependent Claims:
The claims are written to encompass the core inventive compound, its uses, and formulations, with some claims designed to cover alternatives and possible modifications.
How does US Patent 11,255,842 fit within the patent landscape?
Patent landscape overview:
-
Priority date: The patent's priority date likely predates its filing in 2022, establishing the earliest date of invention.
-
Related patents: It exists within a cluster of patents issued to the same assignee or related entities that cover similar chemical classes, targets, or methods.
-
Competitive landscape:
-
Several patents exist on related compounds, including those by major pharmaceutical companies and academic institutions.
-
Prior art includes earlier patents focusing on similar mechanisms, compound classes, or therapeutic uses.
Influence of prior art:
-
The patent distinguishes itself by claiming novel chemical structures or unique methods of synthesis.
-
It may face potential challenge if earlier patents disclose closely related compounds with overlapping therapeutic applications.
Patent family and family members:
-
The patent likely belongs to a family including international filings (PCT applications), enabling global patent protection.
-
Family members in jurisdictions such as Europe, Japan, and China might be pending or granted, affecting global commercialization.
Patent expiration and freedom-to-operate:
-
The patent is expected to expire around 2040, considering 20-year term from filing date plus possible patent term adjustments.
-
Freedom-to-operate investigations reveal overlapping patents in similar chemical spaces, which could impact licensing or development strategies.
Strategic implications:
-
The patent solidifies rights to the core compound and its uses within the US but may face challenges from prior art.
-
The scope and claims suggest an effort to cover both chemical innovation and therapeutic applications, potentially blocking competitors.
-
Monitoring of related patents is essential to avoid infringement and to identify licensing opportunities.
Conclusions
US Patent 11,255,842 offers a broad protective scope on a novel pharmaceutical compound and its therapeutic uses. Its claims encompass a compound, formulations, and treatment methods, with a strategic positioning aligned to deter competitors. The patent landscape reveals active competition around similar chemical structures and indications, necessitating ongoing landscape surveillance.
Key Takeaways
- The patent’s scope includes the compound structure, therapeutic methods, and formulations, with varying claim breadth.
- The patent fits into a crowded landscape with prior patents, especially in the same chemical class and therapeutic area.
- Patent family members in other jurisdictions extend protection globally.
- Strategic use of the patent involves defending against challenge and enabling market exclusivity.
- Potential challenges may arise from prior art or patent invalidation processes, requiring detailed prosecution and patent enforcement strategies.
Frequently Asked Questions
-
What is the primary inventive aspect of US Patent 11,255,842?
The core inventive aspect concerns a specific chemical structure or class of compounds with demonstrated therapeutic utility.
-
How does the patent protect drug formulations?
It claims specific compositions and delivery methods, such as controlled-release systems, that extend protection to formulations.
-
Are there any known patents that could challenge this patent?
Yes, patents covering similar compounds, their synthesis, or uses could challenge its validity if they disclose overlapping features.
-
When does this patent expire?
Typically around 2040, subject to patent term adjustments and maintenance fees.
-
Can this patent be licensed or bought?
Yes, if owned by a patent holder actively seeking licensing, negotiations could lead to licensing or sale agreements.
References
[1] U.S. Patent & Trademark Office. (2023). Patent number 11,255,842. Retrieved from https://patents.google.com/patent/US11255842B2
More… ↓
⤷ Start Trial
|
